• OPEN AN ACCOUNT
Indian Indices
Sensex
85,041.45 -367.25
( -0.43%)
Global Indices
Nasdaq
48,728.27 -23.90
(-0.05%)
Dow Jones
6,949.98 -3.07
(-0.04%)
Hang Seng
50,641.54 233.75
(0.46%)
Nikkei 225
9,870.68 -18.54
(-0.19%)
Forex
USD-INR
89.83 0.26
(0.29%)
EUR-INR
105.77 0.25
(0.24%)
GBP-INR
121.29 0.43
(0.36%)
JPY-INR
0.58 0.00
(0.43%)

EQUITY - MARKET SCREENER

Aptus Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
544529
INE15XJ01010
29.1342566
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
109.76
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 
Particulars(INCOME)Mar 2025
( Cr)
Mar 2024
( Cr)
Mar 2023
( Cr)
Sales Turnover 24.5617.8613.90
Excise Duty0.000.000.00
Net Sales24.5617.8613.90
Other Income 0.080.030.00
Stock Adjustments 3.631.130.90
Total Income28.2719.0214.80
EXPENDITURE :
Raw Materials 12.677.955.67
Power & Fuel Cost0.000.010.00
Employee Cost 3.472.311.57
Other Manufacturing Expenses 2.032.773.28
Selling & Administrative Expenses 4.944.233.41
Miscellaneous Expenses 0.230.170.25
Less : Pre-operative Expenses Capitalised 0.000.000.00
Total Expenditure23.3417.4314.19
Operating Profit4.931.570.62
Interest 0.470.240.14
Gross Profit4.461.330.48
Depreciation0.270.210.18
Profit Before Tax4.191.120.30
Tax1.110.340.12
Fringe Benefit tax0.000.000.00
Deferred Tax-0.02-0.02-0.02
Reported Net Profit3.100.800.19
Extraordinary Items 0.000.000.00
Adjusted Net Profit3.100.800.19
Adjustment below Net Profit -3.050.00-0.08
P & L Balance brought forward1.120.320.20
Statutory Appropriations0.000.000.00
Appropriations 0.000.000.00
P & L Balance carried down1.171.120.32
Dividend0.000.000.00
Preference Dividend0.000.000.00
Equity Dividend %0.000.000.00
Dividend Per Share(Rs)0.000.000.00
Earnings Per Share-Unit Curr6.2026.606.48
Earnings Per Share(Adj)-Unit Curr6.2026.606.48
Book Value-Unit Curr13.9358.8832.28
Book Value(Adj)-Unit Curr13.9358.8832.28